Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1988-01-13 to 1988-02-01
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Version / remarks:
1987-02-24
Deviations:
no
Qualifier:
equivalent or similar to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Version / remarks:
1984-04-25
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Isopropyl acetoacetate
EC Number:
208-798-4
EC Name:
Isopropyl acetoacetate
Cas Number:
542-08-5
Molecular formula:
C7H12O3
IUPAC Name:
propan-2-yl 3-oxobutanoate
Test material form:
liquid

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: HOECHST AG
- Females nulliparous and non-pregnant: not detailed
- Rationale for use of males: according to guideline followed for a limit test each 5 females and 5 males should be used
- Age at study initiation: female: ca. 7 weeks, males: ca. 8 weeks
- Weight at study initiation: female: 190 ± 2.1 g, males: 201 ± 7.7 g
- Fasting period before study: yes, ca. 16 h before study; additionally 3-4 h after application
- Housing: 5 animals per cage, Makrolon cages Typ 4 with wooden bedding
- Diet: ad libitum, rat diet Altromin 1324
- Water: ad libitum, tap water
- Acclimation period: at least 5 days
- Microbiological status when known
- Method of randomisation in assigning animals to test and control groups: accoring to schedule 931/87 and 1399/87

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 50 ± 20
- Air changes (per hr): not detailed, but air condition in animal rooms
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: sesame oil (Oleum Sesami)
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 20 %
- Amount of vehicle: 10 mL/kg bw
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observation: after 10, 30 min, 1, 2, 4, 6 h and afterwards once per day; weighing: once per week
- Necropsy of survivors performed: yes
- Examinations performed: clinical signs, body weight, macroscopic changes
Statistics:
no details provided

Results and discussion

Preliminary study:
A preliminary study was performed with the test item at a concentration of 10 % in sesame oil. Doses of 500, 1000 and 2000 mg/kg bw were administered to each one female and male animal per dose group. They were observed for 14 days and body weight was recorded. All animals showed general signs of toxicity and difficulties with breathing. An increase of body weight was observed in all animals independent on dose group. All animals were sacrificed after observation period and no macroscopic changes were detected.
Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality was observed.
Clinical signs:
other: Crouched position, retracted flanks, stalked and uncoordinated movement and uneven breathing were observed in animals of both sexes in the first hours and the first day after treatment. Starting from the second day after treatment no clinicals signs were
Gross pathology:
No macroscopic changes were detected.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The acute oral toxicity LD50 of the test item was greater than 2000 mg/kg bw in rats.
Executive summary:

The acute oral toxicity of the test item was assessed in a study according to OECD 401 in rats. Animals of both sexes, each 5, were treated with 2000 mg/kg bw by gavage. Afterwards animals were observed for 14 days. During this time no animals died and the body weight gain was not affected by treatment. The animals showed signs of toxicity such as crouched position, retracted flanks, stalked and uncoordinated movement and uneven breathing in the first hours and on the first day after treatment. From the second day after treatment onwards no clinical signs were observed. Macroscopic examination after sacrifice at the end of the observation period showed no changes. Based on the results of the study the LD50 for acute oral toxicity was determined to be greater than 2000 mg/kg bw.